184 related articles for article (PubMed ID: 9041486)
1. Reasons for cervical cancer despite extensive screening.
Stenkvist B; Söderström J
J Med Screen; 1996; 3(4):204-7. PubMed ID: 9041486
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
3. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
4. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
5. Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
Reed BD
Arch Fam Med; 1996; 5(10):582-4. PubMed ID: 8930230
[No Abstract] [Full Text] [Related]
6. Intraepithelial neoplasia of the uterine cervix in the teenager.
Feldman MJ; Kent DR; Pennington RL
Cancer; 1978 Apr; 41(4):1405-8. PubMed ID: 639001
[TBL] [Abstract][Full Text] [Related]
7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
8. Tubal ligation frequency in Oklahoma women with cervical cancer.
Mathews CA; Stoner JA; Wentzensen N; Moxley KM; Tenney ME; Tuller ER; Myers T; Landrum LM; Lanneau G; Zuna RE; Gold MA; Wang SS; Walker JL
Gynecol Oncol; 2012 Nov; 127(2):278-82. PubMed ID: 22858904
[TBL] [Abstract][Full Text] [Related]
9. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in obstetrics and gynecology: The patient with an abnormal Pap smear--screening techniques and management.
Richart RM
N Engl J Med; 1980 Feb; 302(6):332-4. PubMed ID: 6985710
[No Abstract] [Full Text] [Related]
12. Precursor lesions of the cervix.
Moore MD
NAACOGS Clin Issu Perinat Womens Health Nurs; 1990; 1(4):513-24. PubMed ID: 1964388
[TBL] [Abstract][Full Text] [Related]
13. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
15. [Computerised monitoring of integrated cervical screening. Indicators of diagnostic performance].
Bucchi L; Pierri C; Amadori A; Folicaldi S; Ghidoni D; Nannini R; Bondi A
Pathologica; 2003 Dec; 95(6):436-43. PubMed ID: 15080522
[TBL] [Abstract][Full Text] [Related]
16. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
17. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
19. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]